EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSCGOG00000024605
Gene Symbol: DHCR24
3 Cross references
209 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11b-Like

Ensembl ID : ENSCGOG00000021286
Gene Symbol: LOC115024998
3 Cross references
214 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4-Like

Ensembl ID : ENSCGOG00000009141
Gene Symbol: LOC115021282
3 Cross references
221 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4-Like

Ensembl ID : ENSCGOG00000001348
Gene Symbol: LOC115015441
3 Cross references
228 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSCGOG00000007563
Gene Symbol: HMGCR
3 Cross references
194 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Like

Ensembl ID : ENSCGOG00000016256
Gene Symbol: LOC115016396
3 Cross references
206 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2-Like

Ensembl ID : ENSCGOG00000012052
Gene Symbol: LOC115006195
3 Cross references
208 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSCGOG00000006095
Gene Symbol: PDPK1
3 Cross references
222 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSCGOG00000006920
Gene Symbol: LOC115014148
3 Cross references
207 Possible Orthologues:

40s Ribosomal Protein S28

Ensembl ID : ENSCGOG00000019951
Gene Symbol: LOC115022741
3 Cross references
274 Possible Orthologues:

40s Ribosomal Protein S8

Ensembl ID : ENSCGOG00000024652
Gene Symbol: LOC115022134
3 Cross references
327 Possible Orthologues:

40s Ribosomal Protein Sa

Ensembl ID : ENSCGOG00000018572
Gene Symbol: LOC115011839
3 Cross references
516 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).